The global transcatheter heart valve replacement (THVR) market was valued at USD 4.04 billion in 2018 and is expected to grow significantly, reaching around USD 10.34 billion by 2026. This reflects a strong compound annual growth rate (CAGR) of 12.5% over the forecast period. Among all regions, North America led the market, holding a dominant 40.1% share in 2018.

The global transcatheter heart valve replacement (THVR) market is witnessing significant growth, driven by the rising prevalence of valvular heart diseases, an aging population, and increasing adoption of minimally invasive procedures. THVR offers advantages such as reduced hospital stays, faster recovery, and lower procedural risks compared to traditional open-heart surgeries, making it a preferred option among patients and healthcare providers. Advancements in valve technologies, expanding indications for transcatheter procedures, and growing clinical evidence supporting their safety and efficacy are further accelerating market expansion. Additionally, supportive reimbursement policies, increasing awareness among patients, and the presence of strong research and development pipelines are contributing to market development. With continuous innovation and the broadening of treatment options, the THVR market is expected to maintain robust growth in the coming years.

Continue reading for more details:

**https://www.fortunebusinessinsights.com/transcatheter-heart-valve-replacement-market-105572**

Market Segmentation

• By valve type, the transcatheter heart valve replacement market is segmented into transcatheter aortic valve replacement (TAVR) and transcatheter mitral valve replacement (TMVR).
• Based on valve material and design, segments include self‑expanding valves, balloon‑expandable valves, and polymeric valve options in the transcatheter heart valve replacement market.
• By patient risk profile, the market is categorized into high‑risk, intermediate‑risk, and low‑risk patients for transcatheter heart valve replacement market therapies.
• By end user, the transcatheter heart valve replacement market is split between hospitals, cardiac specialty centers, and ambulatory surgical centers.
• Geographically, therapeutic adoption differs across regions within the transcatheter heart valve replacement market, influencing segmentation by regional healthcare infrastructure.

List Of Key Companies Profiled:

• Edwards Lifesciences Corporation
• Abbott
• Medtronic
• LivaNova PLC
• Boston Scientific Corporation
• CryoLife, Inc.
• Micro Interventional Devices, Inc.
• Others